Tag Archives: Dr. Sharmila Bapat

Platform for Identifying Heterogeneity of Cancer Cells

Cancer cells remaining undetected in the body following treatment regimens can cause recurrence. Recent studies suggest that this debilitating issue could be a result of heterogeneous characteristics of cancer cells; thus residual cells are likely to be drug resistant and/or not targeted by the initial treatment. Scientists at NCCS believe that identifying the heterogeneity of the cancer cells and providing a targeted therapy specific for different cell fractions can resolve this issue. Continue reading

An Overview of NCCS Capabilities

Capability Area NCCS Scientists/ Consultants
Cancer Biology Dr. Sharmila Bapat, Dr. Padma Shastry, Dr. Anjali Shiras, Dr. Mohan Wani, Dr. Gopal Kundu, Dr. Samit Chattopadhyay, Dr. Manoj Kumar Bhat, Dr. Sandhya Sitaswad, Dr. Girdhari Lal, Dr. Srikanth Rapole, Dr. Manas Santra
Cell Biology Dr. Shekhar Mande, Dr. Mohan Wani, Dr. Debashis Mitra, Dr. Prakash Deshpande, Dr. Jomon Joseph,  Dr. Bhaskar Saha, Dr. Milind Patole, Dr. Arvind Sahu, Dr. M. V. Krishnasastry, Dr. Vasudevan Seshadri, Dr. Radha Chauhan, Dr. Janesh Kumar, Dr. Girdhari Lal, Dr. Shailza Singh, Dr. Deepa Subramanyam
Genetics Dr. Sharmila Bapat, Dr. Anjali Shiras, Dr. Samit Chattopadhyay, Dr. Jomon Joseph, Dr. Vasudevan Seshadri, Dr. Manas Santra, Dr. Vidisha Tripathi
Immunology  Dr. Mohan Wani, Dr. Bhaskar Saha, Dr. Arvind Sahu, Dr. Girdhari Lal, Dr. Shailza Singh
Metabolic Diseases Dr. Manoj Kumar Bhat, Dr. Sandhya Sitaswad
Microbial Biology Dr. Milind Patole, Dr. Yogesh Shouche, Dr. Shailza Singh
Neuroscience Dr. Amitabha Majumdar, Dr. Janesh Kumar
Stem Cells Dr. Vaijayanti Kale, Dr. Lalita Limaye, Dr. Anjali Shiras, Dr. Nibedita Lenka, Dr. Deepa Subramanyam